Insider trades
Hollings Renton, Director of Anaptysbio ANAB, has filed 0 purchases and 9 sales on the open market. The latest trade was on 06/15.
Hollings Renton
Director
- Company
- Anaptysbio ANAB
- First filing
- 23/01/10
- Trades
- 52 trades
- Buys / sales
- 0 / 9
- 12-month net buying
- No record
- Last trade
- 06/15
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ANAB | Open-market sale10b5-1 plan | 25/08/08 | 25/08/12 | 10,231 sh2 trades | $19.62avg. | $200,742.1 | −67.3% |
ANAB | Open-market sale10b5-1 plan | 25/07/02 | 25/07/03 | 20,925 sh2 trades | $23.57avg. | $493,141 | −80.8% |
AnaptysbioANAB | Open-market sale10b5-1 plan | 25/06/18 | 25/06/20 | 3,015 sh | $23.97 | $72,269.55 | −37.8% |
AnaptysbioANAB | Open-market sale10b5-1 plan | 24/11/29 | 24/12/03 | 10,000 sh | $25.00 | $250,000 | −83.7% |
ANAB | Open-market sale10b5-1 plan | 24/07/15 | 24/07/17 | 10,000 sh2 trades | $30.64avg. | $306,390.56 | −83.7% |
AnaptysbioANAB | Open-market sale | 24/06/18 | 24/06/18 | 1,950 sh | $23.16 | $45,162 | −50.0% |